Piscataway, NJ (PRWEB) September 04, 2014
Dr. Young has organized a twenty-five center clinical trial network in China, Hong Kong, and Taiwan to test a new therapy for chronic spinal cord injuries using transplantation of umbilical cord blood stem cells, lithium, and intense physical rehabilitation. Phase II clinical trials have been completed and preparations are being made for Phase III trials in China, Norway, India, and the United States. Dr. Young will speak the evening of October 6th on “Running Clinical Trials for Spinal Cord Injury Therapies in the US and China: Differences and Lessons Learned”.
Dr. Young is the Founding Director of the W. M. Keck Center for Collaborative Neuroscience at Rutgers, the State University of New Jersey. He is a Distinguished Professor in the Department of Cell Biology and Neuroscience and also holds the Richard H. Shindell Chair in Neuroscience. The Keck Center was established in 1997 to develop effective treatments for spinal cord injuries and to move these discoveries from laboratory to human lives as rapidly as possible. The research conducted at the Center also is applicable to many other devastating conditions of the central nervous system.
Registration for the 12th NJ Symposium on Biomaterials Science is available at http://www.njbiomaterials.org/biomaterials-symposia.htm
The New Jersey Center for Biomaterials (NJCBM) was founded in 1997. Based at Rutgers, the State University of New Jersey, the center spans academia, industry, and government. Staffed by biomaterial scientists, the Center works to improve health care and quality of life by developing advanced biomedical products for tissue repair and replacement as well as the delivery of pharmaceutical agents. The Center’s technologies have been translated into clinical and pre-clinical products including surgical meshes, cardiovascular stents, bone regeneration scaffolds, and ocular drug delivery systems.
(732) 445 0488 ext. 40001